BRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors

Reuters03-03

BRIEF-Ovid <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors

March 3 (Reuters) - Ovid Therapeutics Inc OVID.O:

OVID THERAPEUTICS APPOINTS PIONEERING INDUSTRY LEADER DR. STELIOS PAPADOPOULOS TO BOARD OF DIRECTORS

Source text: ID:nGNX2hLy66

Further company coverage: OVID.O

(Reuters.Briefs@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2516308631?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-03 22:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2516308631","market":"nz","top_or_hot":-1,"title":"BRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Ovid <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors</title></head><body><p><span>March 3 (Reuters)</span><span> - </span>Ovid Therapeutics Inc <span>OVID.O</span>:</p><ul><li><p>OVID THERAPEUTICS APPOINTS PIONEERING INDUSTRY LEADER DR. STELIOS PAPADOPOULOS TO BOARD OF DIRECTORS</p></li></ul><p>Source text: <span>ID:nGNX2hLy66</span></p><p>Further company coverage: <span>OVID.O</span></p><p> (Reuters.Briefs@thomsonreuters.com)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-03-03 22:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Ovid <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors</title></head><body><p><span>March 3 (Reuters)</span><span> - </span>Ovid Therapeutics Inc <span>OVID.O</span>:</p><ul><li><p>OVID THERAPEUTICS APPOINTS PIONEERING INDUSTRY LEADER DR. STELIOS PAPADOPOULOS TO BOARD OF DIRECTORS</p></li></ul><p>Source text: <span>ID:nGNX2hLy66</span></p><p>Further company coverage: <span>OVID.O</span></p><p> (Reuters.Briefs@thomsonreuters.com)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA19XYGF:1","article_id":"2516308631","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2516308631","pubTimestamp":1741011514,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of DirectorsMarch 3 (Reuters) - Ovid Therapeutics Inc OVID.O:OVID THERAPEUTICS APPOINTS PIONEERING INDUSTR","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","OVID":"Ovid Therapeutics Inc."},"translate_title":"简介-Ovid Therapeutics任命行业先驱领导者Stelios Papadopoulos博士为董事会成员","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OVID":0.9},"content_text":"BRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of DirectorsMarch 3 (Reuters) - Ovid Therapeutics Inc OVID.O:OVID THERAPEUTICS APPOINTS PIONEERING INDUSTRY LEADER DR. STELIOS PAPADOPOULOS TO BOARD OF DIRECTORSSource text: ID:nGNX2hLy66Further company coverage: OVID.O (Reuters.Briefs@thomsonreuters.com)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2516308631","isCrawlerRequest":true}